SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 34.39+6.7%Dec 10 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: chirodoc who wrote (4208)10/21/1997 8:52:00 PM
From: Robert K.  Read Replies (1) of 17367
 
Regarding Hem trauma results. They are known, but not to us. They arnt being published, just disclosed in a highly regarded forum. According to the company results showed "clear benefit", and IMO are good enough to get in a P3, but int aint in p3 till its in it. Anyways "clear benefit"should mean clear benefit. There is your answer. Memingo has surprise potential and news pending showing perhaps more clear benefit. CF has to start showing something soon,
but its too prelim to be meaningful. Liver they want to wrap up, and how that one falls is anyones guess, but since liver clears endotoxin odds are for bpi. Stock behaving nicely.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext